FOLD icon

Amicus Therapeutics

141 hedge funds and large institutions have $1.75B invested in Amicus Therapeutics in 2017 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

5% more funds holding

Funds holding: 134141 (+7)

3.61% more ownership

Funds ownership: 118.25%121.86% (+3.6%)

0% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 44

Holders
141
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
9
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$31.4M
Puts
$12.9M
Net Calls
Net Calls Change

Top Buyers

1 +$70.8M
2 +$30.2M
3 +$14.3M
4
Morgan Stanley
Morgan Stanley
New York
+$11.3M
5
TCP
Tourbillon Capital Partners
New York
+$11M

Top Sellers

1 -$11.4M
2 -$10.4M
3 -$10.3M
4
Axa
Axa
France
-$8.47M
5
SAM
Sectoral Asset Management
Quebec, Canada
-$8.34M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$282K
102
$279K
103
$265K
104
$252K
105
$219K
106
$186K
107
$181K
108
$166K
109
$152K
110
$150K
111
$148K
112
$145K
113
$141K
114
$127K
115
$124K
116
$124K
117
$116K
118
$111K
119
$109K
120
$105K
121
$103K
122
$103K
123
$103K
124
$101K
125
$100K